Related Experiment Video
Updated: Jan 24, 2026

Focal Cerebral Ischemia Model by Endovascular Suture Occlusion of the Middle Cerebral Artery in the Rat
Published on: February 5, 2011
Development and validation of a dynamic nomogram for predicting poor outcomes in patients with internal carotid
Lingyu Zhang1,2, Zhixi Wang3, Lingshan Wu3
11Department of Neurology, Weihai Municipal Hospital, Cheeloo College of Medicine, Shandong University, Weihai, China.
Insights
A new nomogram predicts poor outcomes for patients with internal carotid artery occlusion (ICAO) undergoing endovascular therapy (EVT). This tool aids physicians in making critical decisions for stroke patients with ICAO.
Area of Science:
- Neurology
- Interventional Neuroradiology
- Vascular Surgery
Background:
- Internal carotid artery occlusion (ICAO) presents significant challenges in endovascular therapy (EVT) due to high thrombosis burden and compromised collateral circulation.
- Patients with ICAO undergoing EVT often face unfavorable outcomes, necessitating better predictive tools for risk stratification.
Purpose of the Study:
- To identify independent risk factors associated with poor outcomes in patients with ICAO undergoing EVT.
- To develop and validate a dynamic nomogram for predicting poor outcomes in this patient population.
Main Methods:
- A retrospective analysis of 577 patients from the MARVEL trial (training and internal validation cohorts) and 281 patients from the ACTUAL registry (external validation cohort).
- Least absolute shrinkage and selection operator (LASSO) and multivariate logistic regression were used to identify significant risk factors.
- A dynamic nomogram prediction model was constructed and validated.
Main Results:
- Five factors independently predicted poor outcomes: age, baseline Alberta Stroke Programme Early CT Score, baseline National Institutes of Health Stroke Scale score, baseline American Society of Interventional and Therapeutic Neuroradiology and Society of Interventional Radiology grade, and baseline glucose levels.
- The nomogram demonstrated moderate predictive performance with an area under the curve of 0.786 (internal validation) and 0.795 (external validation).
- Calibration curves showed close alignment with the ideal diagonal line, indicating good model fit.
Conclusions:
- The developed predictive model accurately forecasts poor outcomes for patients with ICAO undergoing EVT.
- This dynamic nomogram serves as a valuable adjunct for physicians and patients' families in operative decision-making.
Objective:
Patients with internal carotid artery occlusion (ICAO) present with a heavy thrombosis burden and bad lateral circulation, which are associated with unfavorable outcomes following endovascular therapy (EVT). In this study, authors explored the risk factors associated with poor outcomes in patients with ICAO undergoing EVT and developed and validated a dynamic nomogram for predicting poor outcomes.
Methods:
Five hundred seventy-seven patients from the multicenter, randomized, double-blind, placebo-controlled MARVEL (Methylprednisolone as Adjunctive to Endovascular Treatment for Acute Large Vessel Occlusion) trial were included in the current retrospective study. The patients, all of whom had ICAO and received EVT between February 2022 and June 2023, were split into training (60%) and internal validation (40%) cohorts. Additionally, 281 patients from the Endovascular Treatment for Acute Anterior Circulation Ischemic Stroke registry (ACTUAL registry) served as the external validation cohort. Least absolute shrinkage and selection operator (LASSO) and multivariate logistic regression analyses were applied to identify risk factors to establish a dynamic nomogram prediction model.
Results:
Five risk factors were independently associated with poor outcome, including age (OR 0.951, 95% CI 0.935-0.968, p < 0.001), baseline Alberta Stroke Programme Early CT Score (OR 1.176, 95% CI 1.075-1.286, p < 0.001), baseline National Institutes of Health Stroke Scale score (OR 0.850, 95% CI 0.801-0.901, p < 0.001), baseline American Society of Interventional and Therapeutic Neuroradiology and Society of Interventional Radiology grade (OR 1.646, 95% CI 1.388-1.951, p < 0.001), and baseline glucose levels (OR 0.891, 95% CI 0.827-0.959, p = 0.002). The prediction model, based on these five factors, showed moderate performance with an area under the curve of 0.786 (95% CI 0.728-0.844) in the internal validation and 0.795 (95% CI 0.743-0.847) in the external validation, with the calibration curve closely aligning with the ideal diagonal line.
Conclusions:
This predictive model can accurately forecast poor outcomes for patients with ICAO undergoing EVT, serving as a useful adjunct in operative decision-making for both physicians and patient families.
Related Concept Videos
Predicting Reaction Outcomes
Reliability and Validity
Internal Receptors
In Vitro Drug Release Testing: Overview, Development and Validation
Internal Energy
Dosage Regimen Designs: Nomograms and Tabulations

